• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hematohepatology: The potential for direct oral anticoagulant "Inflation" in liver transplant candidates.

作者信息

Schaefer Jordan K, Fontana Robert J

机构信息

Department of Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.

Department of Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Res Pract Thromb Haemost. 2023 Feb 16;7(2):100082. doi: 10.1016/j.rpth.2023.100082. eCollection 2023 Feb.

DOI:10.1016/j.rpth.2023.100082
PMID:36908767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9999199/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0093/9999199/a58c65ff8ff5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0093/9999199/a58c65ff8ff5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0093/9999199/a58c65ff8ff5/gr1.jpg

相似文献

1
Hematohepatology: The potential for direct oral anticoagulant "Inflation" in liver transplant candidates.血液肝脏病学：直接口服抗凝剂在肝移植候选者中的“应用热潮”潜力。
Res Pract Thromb Haemost. 2023 Feb 16;7(2):100082. doi: 10.1016/j.rpth.2023.100082. eCollection 2023 Feb.
2
Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.肝移植等待名单上的超额死亡率：意外的政策后果和终末期肝病模型（MELD）膨胀。
Hepatology. 2015 Jan;61(1):285-91. doi: 10.1002/hep.27283. Epub 2014 Oct 29.
3
Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis.肝硬化患者门静脉血栓形成的治疗与临床方面
World J Hepatol. 2015 Dec 18;7(29):2906-12. doi: 10.4254/wjh.v7.i29.2906.
4
The Role of Direct Oral Anticoagulant in Patients with Acute Coronary Syndrome on Single or Dual Antiplatelet Regime: Review of Opportunities and Challenges.直接口服抗凝剂在单药或双联抗血小板治疗的急性冠状动脉综合征患者中的作用：机会与挑战的回顾。
Curr Rev Clin Exp Pharmacol. 2021;16(1):52-63. doi: 10.2174/1574884715666200518091359.
5
Inappropriate Prescription of Direct Oral Anticoagulant Starter Packs.直接口服抗凝剂起始治疗方案的不当处方。
Am J Med. 2021 Mar;134(3):370-373.e1. doi: 10.1016/j.amjmed.2020.06.045. Epub 2020 Aug 18.
6
Need for dental treatment in patients on the waiting list for liver and simultaneous pancreas-kidney transplant at a single center.单一中心等待肝移植及同期胰肾联合移植患者的牙科治疗需求
Rev Col Bras Cir. 2019 Oct 17;46(4):e20192224. doi: 10.1590/0100-6991e-20192224. eCollection 2019.
7
Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience.艾达凝血酶原复合物用于逆转达比加群在心脏移植手术中的抗凝作用：一项机构经验。
Case Rep Cardiol. 2020 Mar 6;2020:6927423. doi: 10.1155/2020/6927423. eCollection 2020.
8
Oral health-related quality of life among pediatric liver transplant candidates.儿科肝移植候选者的口腔健康相关生活质量。
Braz Oral Res. 2020;34:e100. doi: 10.1590/1807-3107bor-2020.vol34.0100. Epub 2020 Aug 28.
9
Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants.等待肝肠联合移植的候选者的死亡率高于等待肝移植的其他候选者。
Liver Transpl. 2003 Jul;9(7):748-53. doi: 10.1053/jlts.2003.50151.
10
Trajectories of anxiety and depression in liver transplant candidates during the waiting-list period.肝移植候选者在等待名单期间焦虑和抑郁的轨迹。
Br J Health Psychol. 2017 Sep;22(3):481-501. doi: 10.1111/bjhp.12241. Epub 2017 May 5.

本文引用的文献

1
Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.在肝硬化患者中，治疗剂量的直接口服抗凝剂会使国际标准化比值和终末期肝病模型评分出现具有临床意义的升高。
Res Pract Thromb Haemost. 2023 Jan 14;7(1):100052. doi: 10.1016/j.rpth.2023.100052. eCollection 2023 Jan.
2
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation.美国肝硬化合并非瓣膜性心房颤动患者口服抗凝药物的处方趋势。
J Am Heart Assoc. 2023 Feb 7;12(3):e026863. doi: 10.1161/JAHA.122.026863. Epub 2023 Jan 10.
3
The Evolution of the MELD Score and Its Implications in Liver Transplant Allocation: A Beginner's Guide for Trainees.
终末期肝病模型（MELD）评分的演变及其在肝移植分配中的意义：实习生入门指南
ACG Case Rep J. 2022 May 4;9(5):e00763. doi: 10.14309/crj.0000000000000763. eCollection 2022 May.
4
AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.美国胃肠病学会肝硬化患者凝血功能障碍管理临床实践指南
Gastroenterology. 2021 Nov;161(5):1615-1627.e1. doi: 10.1053/j.gastro.2021.08.015. Epub 2021 Sep 25.
5
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.MELD 3.0：适应新时代的终末期肝病模型。
Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3.
6
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.2021年欧洲心律协会心房颤动患者使用非维生素K拮抗剂口服抗凝药实用指南。
Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.
7
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.美国血液学会2020年静脉血栓栓塞管理指南：深静脉血栓形成和肺栓塞的治疗
Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
8
Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.直接口服抗凝剂与晚期肝病：系统评价和荟萃分析。
Eur J Clin Invest. 2021 Mar;51(3):e13397. doi: 10.1111/eci.13397. Epub 2020 Sep 27.
9
Anticoagulation in the cirrhotic patient.肝硬化患者的抗凝治疗。
JHEP Rep. 2019 Jul 16;1(3):227-239. doi: 10.1016/j.jhepr.2019.02.006. eCollection 2019 Sep.
10
Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.危重症患者终末期肝病模型（不包括国际标准化比值，即MELD-XI评分）：易于获取且具有预后相关性。
PLoS One. 2017 Feb 2;12(2):e0170987. doi: 10.1371/journal.pone.0170987. eCollection 2017.